article thumbnail

AliveCor's Kardia 12L ECG System Receives Category III CPT Codes

DAIC

CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement. KAI 12L is the world's first AI to detect 35 cardiac determinations, including heart attacks, using a reduced leadset.

article thumbnail

Bridging the Gap: Enhancing Stroke Recovery Through Digital Health Solutions

DAIC

I had had a heart attack previously. Navigating Post-Stroke Recovery at Home: One Patient's Experience A ”mildly impaired” stroke patient with atrial fibrillation who was discharged reported, “I knew my local pharmacist, and they knew my prescriptions. I couldn’t dispense my medications into daily doses.

Stroke 115
article thumbnail

Weight Loss Drugs Land Medicare Coverage for Cardiovascular Events

CardiacWire

Wegovy’s recent FDA approval expansion for CVD events and last week’s Medicare Part D policy expansion both come in response to the SELECT trial , which found that Wegovy slashed patients’ major cardiac event risks by 20% over five years, while cutting non-fatal heart attacks by 28% and reducing cardiovascular mortality by 15%.

article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

Patients treated with CardiAMP cell therapy saw an almost 5% lower rate of heart death equivalents at up to two years compared to control patients treated with heart failure medication alone (8.3% vs. 13.2%, respectively). The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

article thumbnail

Medtronic Receives CMS National Coverage Analysis for Renal Denervation System

DAIC

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.

CMS 52